Skip to main content
Addgene

p21-pRc/CMV Citations (5)

Originally described in: Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors.
Adams PD, Sellers WR, Sharma SK, Wu AD, Nalin CM, Kaelin WG Mol Cell Biol. 1996 Dec . 16(12):6623-33.
PubMed

Articles Citing p21-pRc/CMV

Articles
The anti-proliferative function of the TGF-beta1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3. Li J, Ballim D, Rodriguez M, Cui R, Goding CR, Teng H, Prince S. J Biol Chem. 2014 Dec 19;289(51):35633-43. doi: 10.1074/jbc.M114.596411. Epub 2014 Nov 4. PubMed
The T-box transcription factor TBX3 drives proliferation by direct repression of the p21(WAF1) cyclin-dependent kinase inhibitor. Willmer T, Hare S, Peres J, Prince S. Cell Div. 2016 Apr 22;11:6. doi: 10.1186/s13008-016-0019-0. eCollection 2016. PubMed
VHL promotes immune response against renal cell carcinoma via NF-kappaB-dependent regulation of VCAM-1. Labrousse-Arias D, Martinez-Alonso E, Corral-Escariz M, Bienes-Martinez R, Berridy J, Serrano-Oviedo L, Conde E, Garcia-Bermejo ML, Gimenez-Bachs JM, Salinas-Sanchez AS, Sanchez-Prieto R, Yao M, Lasa M, Calzada MJ. J Cell Biol. 2017 Mar 6;216(3):835-847. doi: 10.1083/jcb.201608024. Epub 2017 Feb 24. PubMed
A novel regulatory function of CDKN1A/p21 in TNFalpha-induced matrix metalloproteinase 9-dependent migration and invasion of triple-negative breast cancer cells. Zaremba-Czogalla M, Hryniewicz-Jankowska A, Tabola R, Nienartowicz M, Stach K, Wierzbicki J, Cirocchi R, Ziolkowski P, Tabaczar S, Augoff K. Cell Signal. 2018 Jul;47:27-36. doi: 10.1016/j.cellsig.2018.03.010. Epub 2018 Mar 26. PubMed
pVHL-mediated regulation of the anti-angiogenic protein thrombospondin-1 decreases migration of Clear Cell Renal Carcinoma Cell Lines. Sevilla-Montero J, Bienes-Martinez R, Labrousse-Arias D, Fuertes-Yebra E, Ordonez A, Calzada MJ. Sci Rep. 2020 Jan 24;10(1):1175. doi: 10.1038/s41598-020-58137-w. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.